within Pharmacolibrary.Drugs.D_Dermatologicals.D03A_Cicatrizants.D03AX09_Crilanomer;
model Crilanomer 
   extends Pharmacolibrary.Drugs.ATC.D.D03AX09;

  annotation(Documentation(
    info ="<html><body><p>Crilanomer is a topical wound healing agent classified under ATC code D03AX09. It was investigated as a polymeric compound intended for dermatological use, most notably in the treatment of chronic wounds and ulcers. There is no evidence that crilanomer is approved or widely used today; its development appears to have been discontinued and it is not generally available.</p><h4>Pharmacokinetics</h4><p>No published human or animal pharmacokinetic data for crilanomer are available. No clinical studies describing its absorption, distribution, metabolism, or excretion have been found.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Crilanomer;
